The Swiss Stock Exchange welcomes Exane Solutions (Luxembourg) SA as the 21st issuer for structured products and Exane Derivatives SNC as a new trading participant. The first product, a tracker certificate on the Exane Apollo Index in Euro, has been listed on 22 January 2021.
Christian Reuss, Head SIX Swiss Exchange, Markets, SIX, said:
“We are pleased to welcome Exane as a long-standing provider of innovative structured products among our issuers. By listing their products on our exchange they are offering investors an additional diversification opportunity.”
Julien Morizot, Head of Exane Derivatives Sales, commented:
“We have chosen to become a member and authorized issuer at SIX in order to strengthen our market position in Switzerland. Exane and more particularly our structured products teams have been working in Geneva for more than ten years.”
Founded in 1990, the Exane Group is based on a robust business model built around three complementary business lines: Equity Intermediation (Exane BNP Paribas), Derivatives (Exane Derivatives), Asset Management (Exane Asset Management, Ellipsis AM and Ixios Asset Management). In order to be as close as possible to its clients, Exane has expanded internationally, with Paris and London being its main locations. Today, 850 employees in nine different locations around the world, are working for Exane.
Exane Derivatives SNC joined the Swiss Stock Exchange on 22 January 2021 as a new trading participant, increasing their number to 96.
With a trading turnover of CHF 22.6 billion and a total of 898,304 trades, 2020 was a record year for the structured products and warrants segment of the Swiss Stock Exchange. It aims to offer a solid foundation for trading structured products thanks to maximum transparency, efficiency and dependability.